INTERCEPT
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 22 Feb 2023)
What this means for you
Registered since 04 Oct 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86424518
- Registration number
- 5055185
- Mark type
- Design + words
- Filed
- 15 Oct 2014
- Published for opposition
- 02 Jun 2015
- Registered
- 04 Oct 2016
- Attorney of record
- Jennifer Sheehan Anderson
Goods and services
- Class 005 — Pharmaceuticals: House mark for pharmaceutical preparations used to treat chronic liver and intestinal diseases
Owner
- Intercept Pharmaceuticals, Inc., Morristown, NJ, US
- Intercept Pharmaceuticals, Inc., New York, NY, US
- Intercept Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 04 Oct 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Feb 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Feb 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 22 Feb 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Aug 2022 — TEAS SECTION 8 & 15 RECEIVED
- 04 Oct 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Sept 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Oct 2016 — REGISTERED-PRINCIPAL REGISTER
- 30 Aug 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Aug 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Aug 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Jul 2016 — USE AMENDMENT FILED
- 19 Aug 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Jul 2016 — TEAS STATEMENT OF USE RECEIVED
- 19 Jan 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED